Exhibit 2.2
TRIANGLE PHARMACEUTICALS, INC.
INVESTOR RIGHTS AGREEMENT
THIS INVESTOR RIGHTS AGREEMENT (the "RIGHTS AGREEMENT") is entered into
as of the 9th day of December, 2002, by and among TRIANGLE PHARMACEUTICALS,
INC., a Delaware corporation (the "COMPANY") and GILEAD SCIENCES, INC., a
Delaware corporation (the "PURCHASER").
RECITALS
WHEREAS, the Company will issue to the Purchaser a Convertible Note (as
defined below) which is convertible into Common Stock of the Company; and
WHEREAS, in order to induce the Purchaser to purchase the Note, the
Company has agreed to provide the registration rights set forth in this Rights
Agreement for the benefit of the Purchaser.
NOW, THEREFORE, in consideration of the mutual promises,
representations, warranties, covenants and conditions set forth in this Rights
Agreement and the Note, the parties mutually agree as follows:
SECTION 1. GENERAL.
1.1 DEFINITIONS. As used in this Rights Agreement the following terms
shall have the following respective meanings:
"APPROVED MARKET" means the New York Stock Exchange, the American Stock
Exchange, the Nasdaq National Market or the Nasdaq Small Cap Market.
"COMMON STOCK" means the Company's Common Stock, $0.001 par value.
"CONVERSION SHARES" means the shares of the Company's Common Stock
issuable upon conversion of the Convertible Note.
"CONVERTIBLE NOTE CLOSING DATE" means the date of the closing of the
sale of the Convertible Note.
"CONVERTIBLE NOTE" means the Company's 7.50% Convertible Promissory
Note.
"DERIVATIVE TRANSACTIONS" shall mean derivative, hedging or similar
transactions.
"EXCHANGE ACT" means the Securities Exchange Act of 1934, as amended.
"FILING DATE" shall have the meaning set forth in Section 2.2(a).
"FORM S-3" means such form under the Securities Act as in effect on the
date hereof or any successor registration form under the Securities Act
subsequently adopted by the SEC which
1
permits inclusion or incorporation of substantial information by reference to
other documents filed by the Company with the SEC.
"HOLDER" means any person owning of record any shares of the
Registrable Securities that have not been sold to the public or any assignee of
record of such Registrable Securities in accordance with Section 2.9 hereof.
"PURCHASER" means the Purchaser and its transferees and assigns.
"PURCHASER SECURITIES" means the Registrable Securities and the
Convertible Note.
"REGISTER," "REGISTERED," and "REGISTRATION" refer to a registration
(including a shelf registration) effected by preparing and filing a registration
statement in compliance with the Securities Act, and the declaration or ordering
of effectiveness of such registration statement or documents.
"REGISTRABLE SECURITIES" shall mean (i) the Conversion Shares, (ii)
securities issued or issuable upon any stock split, stock dividend,
recapitalization or similar event with respect to the foregoing, and (iii) other
securities issued as a dividend or other distribution with respect to, in
exchange for or in replacement of the securities referred to in the preceding
clauses. Notwithstanding the foregoing, Registrable Securities shall not include
any securities (i) sold by a person to the public either pursuant to a
registration statement or Rule 144, (ii) sold in a private transaction in which
the transferor's rights under Section 2 of this Rights Agreement are not
assigned or (iii) held by a Holder whose registration rights have terminated or
expired under Section 2.6 hereof.
"REGISTRATION EXPENSES" shall mean all expenses (other than Selling
Expenses) incurred by the Company in complying with Section 2.2 hereof,
including, without limitation, all registration and filing fees, printing
expenses, fees and disbursements of counsel for the Company, reasonable fees and
disbursements not to exceed Thirty Thousand Dollars ($30,000) of a single
special counsel for the Holders of Registrable Securities, blue sky fees and
expenses and the expense of any special audits incident to or required by any
such registration (but excluding the compensation of regular employees of the
Company which shall be paid in any event by the Company).
"REGISTRATION STATEMENT" shall have the meaning set forth in Section
2.2.
"SEC" or "COMMISSION" means the Securities and Exchange Commission.
"SECURITIES ACT" shall mean the Securities Act of 1933, as amended.
"SELLING EXPENSES" shall mean all (i) underwriting discounts and
selling commissions applicable to the sale of Registrable Securities, (ii) stock
transfer taxes and (iii) the costs, fees and expenses of any accountants,
attorneys (other than the reasonable fees and disbursements of a single special
counsel for the Holders (not to exceed $15,000) which are Registration Expenses)
or other expert retained by the Holders.
"TRANSACTION DOCUMENTS" means the Convertible Note and this Rights
Agreement.
2
SECTION 2. REGISTRATION; RESTRICTIONS ON TRANSFER.
2.1 RESTRICTIONS ON TRANSFER.
(a) Each Holder agrees not to make any disposition of all or any
portion of the Registrable Securities unless and until:
(i) There is then in effect a registration statement under
the Securities Act covering such proposed disposition and such disposition is
made in accordance with such registration statement; or
(ii) The disposition is made under Rule 144 under the
Securities Act or its equivalent; or
(iii) (A) The transferee has agreed in writing to be bound
by the terms of this Rights Agreement, (B) such Holder shall have notified the
Company of the proposed disposition and shall have furnished the Company with a
statement of the circumstances surrounding the proposed disposition, and (C) if
reasonably requested by the Company upon the written advice of counsel to the
Company, such Holder shall have furnished the Company with an opinion of
counsel, reasonably satisfactory to the Company, that such disposition will not
require registration under the Securities Act.
(iv) Notwithstanding the provisions of paragraphs (i), (ii)
and (iii) above, no such registration statement or opinion of counsel shall be
necessary for a transfer by a Holder which is (A) a partnership to its partners
or former partners in accordance with partnership interests, (B) a corporation
to its shareholders in accordance with their interest in the corporation, or to
a wholly-owned subsidiary or an affiliate of such corporation (the term
"AFFILIATE" being defined herein as any other person or entity directly or
indirectly controlling, controlled by or under common control with such person
or entity, with "CONTROL" meaning the possession, directly or indirectly, of the
power to direct or cause the direction of the management and policies of a
person or entity, whether through the ownership of voting securities or voting
interests, by contract or otherwise), (C) a limited liability company to its
members or former members in accordance with their interest in the limited
liability company, or (D) to such Holder's family member or trust for the
benefit of an individual Holder, provided any such transferee will be subject to
the terms of this Rights Agreement to the same extent as if he were an original
Holder hereunder.
(b) Each certificate representing Registrable Securities shall
(unless the Registration Statement (as defined below) has been declared
effective by the SEC at the time issuance thereof) be stamped or otherwise
imprinted with legends substantially similar to the following (in addition to
any legend required under applicable state securities laws):
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 (THE "ACT") AND MAY NOT BE OFFERED, SOLD OR OTHERWISE
TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER
THE ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT
REQUIRED.
3
(c) The Company agrees to reissue certificates for Registrable
Securities without the legend set forth above (A) upon the effectiveness of the
Registration Statement or (B) within three (3) trading days of receipt of a
written request from the Purchaser, which request shall include such information
as is reasonably necessary for the Company and its counsel to determine that
such Registrable Securities (i) have been sold to a purchaser or purchasers who
(in the opinion of counsel to the seller or such purchaser(s), in form and
substance reasonably satisfactory to the Company and its counsel) are able to
dispose of such shares publicly without registration under the Securities Act,
(ii) have been sold pursuant to an effective registration statement, (iii) may
be sold pursuant to Rule 144(k), or (iv) have been sold in compliance with Rule
144.
(d) Any legend endorsed on an instrument pursuant to applicable
state securities laws and the stop-transfer instructions with respect to such
securities shall be removed upon receipt by the Company of an order of the
appropriate blue sky authority authorizing such removal.
(e) Holder agrees to only dispose of the Registrable Securities
pursuant to the Registration Statement (as defined below) or an exemption from
applicable securities law registration requirements, and otherwise in compliance
with any other applicable rule, regulation or law.
(f) Subject to compliance with applicable law, nothing in this
Rights Agreement will restrict any Holder from engaging in Derivative
Transactions with respect to the Purchaser Securities. Furthermore, nothing
herein shall limit the right of any Holder to pledge the Purchaser Securities
pursuant to a bona fide margin account or lending arrangement entered into in
compliance with law, including applicable securities laws.
2.2 REQUIRED REGISTRATION. The Company shall use its best efforts to
effect the registration of the Registrable Securities (including without
limitation the execution of an undertaking to file post-effective amendments,
appropriate qualification under applicable Blue Sky or other state securities
laws and appropriate compliance with applicable regulations issued under the
Securities Act) as would permit or facilitate the sale or distribution of all
the Registrable Securities in the manner (including manner of sale) reasonably
requested by a Holder and in all U.S. jurisdictions. Such best efforts by the
Company shall include the following:
(a) The Company shall, as expeditiously as reasonably possible
after the first date upon which the Convertible Promissory Note is convertible
under its terms:
(i) But in any event within fifteen (15) days thereafter
(the "FILING DATE"), prepare and file a shelf registration statement with the
Commission on Form S-3 under the Securities Act (or in the event that the
Company is ineligible to use such form, such other form as the Company is
eligible to use under the Securities Act) covering the sale from time to time by
each Holder of any Registrable Securities (such registration statement,
including any amendments or supplements thereto and prospectuses contained
therein, and any additional registration statement(s) as may be necessary to
permit the disposition of all Registrable Securities, is referred to herein as
the "REGISTRATION STATEMENT"), which Registration Statement, to the extent
allowable under the Securities Act and the rules promulgated thereunder
(including
4
Rule 416), shall also cover such number of additional shares of Common Stock as
may become issuable to prevent dilution resulting from stock splits, stock
dividends or similar events. The number of shares of Common Stock initially
included in the initial Registration Statement shall not exceed the number of
shares allowed under Rule 415; PROVIDED that such number of shares of Common
Stock shall be not less than the number of shares of Common Stock into which the
Convertible Note and any interest that may accrue during the term thereof may be
converted. Thereafter, the Company shall use its best efforts to cause such
Registration Statement to be declared effective as soon as practicable. The
Company shall provide each Holder and its legal counsel reasonable opportunity,
but not less than three (3) full business days, to review the Registration
Statement or amendment or supplement thereto prior to filing. Without limiting
the foregoing, the Company will promptly respond to all SEC comments, inquiries
and requests and shall provide each Holder with copies of all correspondence in
connection therewith, and shall request acceleration of effectiveness at the
earliest practicable date.
(ii) Prepare and file with the SEC such amendments and
supplements to such Registration Statement and the prospectus used in connection
with such Registration Statement, or prepare and file such additional
registration statements, as may be necessary to comply with the provisions of
the Securities Act with respect to the disposition of all Registrable Securities
and promptly notify each Holder of the filing and effectiveness of such
Registration Statement and any amendments or supplements or additional
registration statements.
(iii) After the registration, furnish to each Holder such
numbers of copies of a current prospectus conforming with the requirements of
the Securities Act, copies of the Registration Statement, any amendment or
supplement thereto and any documents incorporated by reference therein and such
other documents as such Holder may reasonably require in order to facilitate the
disposition of Registrable Securities owned by such Holder.
(iv) Use its best efforts to register and qualify the
securities covered by such Registration Statement under such other securities or
Blue Sky laws of all U.S. jurisdictions; PROVIDED that the Company shall not be
required in connection therewith or as a condition thereto to qualify to do
business or to file a general consent to service of process in any such states
or jurisdictions.
(v) Notify each Holder immediately of the happening of any
event as a result of which the prospectus (including any supplements thereto or
thereof and any information incorporated or deemed to be incorporated by
reference therein) included in such Registration Statement, as then in effect,
includes an untrue statement of material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing, and use its best efforts
to promptly update and/or correct such prospectus.
(vi) Notify each Holder immediately of the issuance by the
SEC or any state securities commission or agency of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any
proceedings for that purpose. The Company shall use its best efforts to prevent
the issuance of any stop order and, if any stop order is issued, to obtain the
lifting thereof at the earliest possible time.
5
(vii) Use its best efforts to list the Registrable
Securities covered by such Registration Statement with all securities
exchange(s) and/or markets on which the Common Stock is then listed and prepare
and file any required filings with the National Association of Securities
Dealers, Inc. or any exchange or market where the Common Stock is then traded.
(viii) If applicable, take all steps necessary to enable
each Holder to avail itself of the prospectus delivery mechanism set forth in
Rule 153 (or successor thereto) under the Securities Act.
(b) The Company shall supplement or amend the Registration
Statement or cause the related prospectus to be amended or supplemented if
required under the Securities Act or by the rules, regulations or instructions
applicable to the registration form used for such Registration Statement or with
respect to updated information about the Purchaser of Registrable Securities,
use its best efforts to cause any such amendment to become effective and such
Registration Statement or related prospectus to become usable as soon as
practicable thereafter and promptly furnish to each Holder of Registrable
Securities included in the Registration Statement copies of any such supplement
or amendment.
(c) Holder of Registrable Securities agrees, by acquisition of
such Registrable Securities that, upon actual receipt of any notice from the
Company pursuant to Section 2.2(a)(v) or Section 2.5(e), such Holder will
immediately discontinue any sales of such Registrable Securities (a
"SUSPENSION") until such Holder's receipt of an amended Registration Statement,
supplemented or amended prospectus thereunder, or until it is advised in writing
by the Company that the use of the applicable Registration Statement may be
resumed. Notwithstanding the foregoing, such Holder shall not be prohibited from
selling Registrable Securities under the Registration Statement as a result of
Suspensions on more than two (2) occasions in any twelve (12) month period, each
such Suspension lasting no longer than the lesser of (a) sixty (60) days and (b)
the period commencing on the first day of such Suspension and ending on the day
on which a shareholder of the Company other than such Holder has the ability to
sell securities of the Company under an effective Registration Statement on Form
S-3), unless, in the good faith judgment of the Company's Board of Directors,
upon written advice of counsel to the Company, the sale of Registrable
Securities under the Registration Statement in reliance on this paragraph would
be reasonably likely to cause a violation of the Securities Act or the Exchange
Act and result in potential liability to the Company.
2.3 VOLUME LIMITATIONS ON TRANSFERS. The Holder expressly covenants and
agrees not to offer, pledge, sell, contract to sell, sell any option or contract
to purchase, purchase any option or contract to sell, grant any option, right or
warrant to purchase, or otherwise transfer or dispose of (such event, a
"Transfer"), directly or indirectly, a number of Registrable Securities greater
than three percent (3%) of the outstanding shares of Company common stock per
calendar quarter, measured as of the first day of such calendar quarter;
provided however, that, subject to compliance with applicable securities laws,
such Holder shall be permitted to Transfer, in one or more private transactions,
a "block" (as such term is defined in Rule 10b-18(a) of the Exchange Act) of
Registrable Securities without violating the provisions of this Section 2.3.
6
2.4 EXPENSES OF REGISTRATION. All Registration Expenses incurred in
connection with the Registration Statement herein shall be borne by the Company.
All Selling Expenses incurred in connection with the Registration Statement
shall be borne by the Holders pro rata on the basis of the number of shares
sold.
2.5 OBLIGATIONS OF THE COMPANY. Without limiting the requirements of
Section 2.2, the Company shall:
(a) Keep the Registration Statement effective for up two (2)
years or, if earlier, (i) until each Holder has completed the distribution
related thereto, or (ii) the date on which the Registrable Securities may be
resold by each Holder without restriction by the volume limitations of Rule
144(e) under the Securities Act.
(b) Prepare and file with the SEC such amendments and
supplements to the Registration Statement and the prospectus used in connection
with the Registration Statement as may be necessary to comply with the
provisions of the Securities Act with respect to the disposition of all
securities covered by the Registration Statement.
(c) Furnish to each Holder such number of copies of a
prospectus, including a preliminary prospectus, in conformity with the
requirements of the Securities Act, and such other documents as they may
reasonably request in order to facilitate the disposition of Registrable
Securities being registered by them.
(d) Register and qualify the securities covered by such
registration statement under such other securities or Blue Sky laws of such
jurisdictions as shall be reasonably requested by such Holder.
(e) Notify each Holder covered by the Registration Statement at
any time when a prospectus relating thereto is required to be delivered under
the Securities Act of the happening of any event as a result of which the
prospectus included in the Registration Statement, as then in effect, includes
an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading in the light of the circumstances then existing, and promptly file,
and use its best efforts to cause to become effective, an amendment to such
registration statement to cause the Registration Statement not to include an
untrue statement of material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading in
light of the circumstances then existing.
2.6 TERMINATION OF REGISTRATION RIGHTS. All registration rights granted
under this Section 2 shall terminate and be of no further force and effect seven
(7) years after the Convertible Note Closing Date. Notwithstanding the
foregoing, each Holder's registration rights shall expire if (i) all Registrable
Securities held by and issuable to such Holder may be sold under Rule 144(k)
under the Securities Act.
2.7 FURNISHING INFORMATION. It shall be a condition precedent to the
obligations of the Company to take any action pursuant to Section 2.2 that a
Holder shall furnish to the Company such information regarding itself, the
Registrable Securities held by it and the intended
7
method of disposition of such securities as shall be required to effect the
registration of Registrable Securities.
2.8 INDEMNIFICATION.
(a) To the extent permitted by law, the Company will indemnify
and hold harmless each Holder, the partners, officers, affiliates, directors and
legal counsel of such Holder, any underwriter (as defined in the Securities Act)
for such Holder and each person, if any, who controls such Holder or underwriter
within the meaning of the Securities Act or the Exchange Act (each, a "HOLDER
INDEMNIFIED PERSON"), against any losses, claims, damages, or liabilities (joint
or several) to which they may become subject under the Securities Act, the
Exchange Act or other federal or state law, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based
upon any of the following statements, omissions or violations (collectively a
"VIOLATION") by the Company: (i) any untrue statement or alleged untrue
statement of a material fact contained in the Registration Statement, including
any preliminary prospectus or final prospectus contained therein or any
amendments or supplements thereto, (ii) the omission or alleged omission to
state therein a material fact required to be stated therein, or necessary to
make the statements therein not misleading, or (iii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act, any state
securities law or any rule or regulation promulgated under the Securities Act,
the Exchange Act or any state securities law in connection with the offering
covered by the Registration Statement; and the Company will reimburse (as and
when incurred from time to time) each Holder Indemnified Person for any legal or
other expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability or action or enforcing the
provisions of this Section 2.8; PROVIDED, HOWEVER, that the indemnity agreement
contained in this Section 2.8(a) shall not apply to amounts paid in settlement
of any such loss, claim, damage, liability or action if such settlement is
effected without the consent of the Company, which consent shall not be
unreasonably withheld, nor shall the Company be liable in any such case for any
such loss, claim, damage, liability or action to the extent that it arises out
of or is based upon a Violation which occurs in reliance upon and in conformity
with written information furnished expressly for use in connection with such
registration by such Holder Indemnified Person.
(b) To the extent permitted by law, each Holder will, indemnify
and hold harmless the Company, each of its directors, its officers, affiliates
and legal counsel and each person, if any, who controls the Company within the
meaning of the Securities Act, and any underwriter (each, a "COMPANY INDEMNIFIED
PERSON" and, together with the Holder Indemnified Persons, "INDEMNIFIED PARTY")
against any losses, claims, damages or liabilities to which the Company or any
such director, officer, affiliate, controlling person or underwriter may become
subject under the Securities Act, the Exchange Act or other federal or state
law, insofar as such losses, claims, damages or liabilities (or actions in
respect thereto) arise out of or are based upon any Violation, in each case to
the extent (and only to the extent) that such Violation occurs in reliance upon
and in conformity with written information furnished by such Holder under an
instrument duly executed by such Holder and stated to be specifically for use in
connection with the Registration Statement; and the Purchaser will reimburse (as
and when incurred from time to time) any legal or other expenses reasonably
incurred by the Company or any such director, officer, controlling person or
underwriter in connection with investigating or defending any such loss, claim,
damage, liability or action; PROVIDED, HOWEVER, that the indemnity agreement
8
contained in this Section 2.8(b) shall not apply to amounts paid in settlement
of any such loss, claim, damage, liability or action if such settlement is
effected without the consent of such Holder, which consent shall not be
unreasonably withheld; PROVIDED FURTHER, that in no event shall any indemnity
under this Section 2.8 exceed the net proceeds from the offering received by
such Holder.
(c) Promptly after receipt by an Indemnified Party under this
Section 2.8 of notice of the commencement of any action (including any
governmental action), such Indemnified Party will, if a claim in respect thereof
is to be made against any indemnifying party under this Section 2.8, deliver to
the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties; PROVIDED, HOWEVER, that an Indemnified Party shall
have the right to retain its own counsel, with the reasonable fees and expenses
to be paid by the indemnifying party, if the Indemnified Party determines that
representation of such Indemnified Party by the counsel retained by the
indemnifying party would be inappropriate due to actual or potential differing
interests between such Indemnified Party and any other party represented by such
counsel in such proceeding or if the counsel retained by the indemnifying party
fails to assume the representation of the Indemnified Party. The failure to
deliver written notice to the indemnifying party within a reasonable time of the
commencement of any such action, shall not relieve such indemnifying party of
any liability to the Indemnified Party under this Section 2.8, except to the
extent that the indemnifying party is materially prejudiced by such delay, but
the omission so to deliver written notice to the indemnifying party will not
relieve it of any liability that it may have to any Indemnified Party otherwise
than under this Section 2.8.
(d) If the indemnification provided for in this Section 2.8 is
held by a court of competent jurisdiction to be unavailable to an Indemnified
Party with respect to any losses, claims, damages or liabilities referred to
herein, the indemnifying party, in lieu of indemnifying such Indemnified Party
thereunder, shall to the extent permitted by applicable law contribute to the
amount paid or payable by such Indemnified Party as a result of such loss,
claim, damage or liability in such proportion as is appropriate to reflect the
relative fault of the indemnifying party on the one hand and of the Indemnified
Party on the other in connection with the Violation(s) that resulted in such
loss, claim, damage or liability, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the
Indemnified Party shall be determined by a court of law by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact
or the omission to state a material fact relates to information supplied by the
indemnifying party or by the Indemnified Party and the parties' relative intent,
knowledge, access to information and opportunity to correct or prevent such
statement or omission; PROVIDED, that in no event shall any contribution by a
Holder hereunder exceed the proceeds from the offering received by such Holder.
No person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation.
(e) The obligations of the Company and each Holder under this
Section 2.8 shall survive completion of any offering of Registrable Securities
in the Registration Statement. No indemnifying party, in the defense of any such
claim or litigation, shall, except with the
9
consent of each Indemnified Party, consent to entry of any judgment or enter
into any settlement which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnified Party of a release from
all liability in respect to such claim or litigation.
2.9 ASSIGNMENT OF REGISTRATION RIGHTS. The rights to cause the Company
to register Registrable Securities pursuant to this Section 2 may be assigned by
the Purchaser to any transferee or assignee of Registrable Securities which (i)
is a person or entity which holds Registrable Securities, as the case may be,
pursuant to a transfer permitted by Section 2.1, or (ii) acquires at least one
million (1,000,000) shares of Registrable Securities (as adjusted for stock
splits and combinations).
2.10 RULE 144 REPORTING. With a view to making available to the
Purchaser the benefits of certain rules and regulations of the SEC which may
permit the sale of the Registrable Securities to the public without
registration, the Company agrees to use its best efforts to:
(a) Make and keep public information available, as those terms
are understood and defined in SEC Rule 144 or any similar or analogous rule
promulgated under the Securities Act, at all times after the effective date of
the first registration filed by the Company for an offering of its securities to
the general public;
(b) File with the SEC, in a timely manner, all reports and other
documents required of the Company under the Exchange Act; and
(c) So long as Purchaser owns any Registrable Securities,
furnish to the Purchaser forthwith upon request: a written statement by the
Company as to its compliance with the reporting requirements of said Rule 144 of
the Securities Act, and of the Exchange Act (at any time after it has become
subject to such reporting requirements); a copy of the most recent annual or
quarterly report of the Company; and such other reports and documents as a
Holder may reasonably request in availing itself of any rule or regulation of
the SEC allowing it to sell any such securities without registration.
SECTION 3. MISCELLANEOUS.
3.1 GOVERNING LAW; JURISDICTION; WAIVER OF JURY TRIAL. THIS RIGHTS
AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW
YORK APPLICABLE TO CONTRACTS EXECUTED AND TO BE PERFORMED ENTIRELY WITHIN THAT
STATE. EACH OF THE PARTIES HEREBY SUBMITS TO THE EXCLUSIVE PERSONAL JURISDICTION
AND WAIVE ANY OBJECTION AS TO VENUE IN EITHER (I) THE STATE OF DELAWARE OR (II)
THE COUNTY OF SAN FRANCISCO, STATE OF CALIFORNIA. THE PARTIES HERETO WAIVE ALL
RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY
RIGHTS UNDER THIS RIGHTS AGREEMENT.
3.2 SURVIVAL. The representations, warranties, covenants, and
agreements made herein shall survive any investigation made by the Purchaser and
the closing of the transactions contemplated hereby. All statements as to
factual matters contained in any certificate or other instrument delivered by or
on behalf of the Company pursuant hereto in connection with the
10
transactions contemplated hereby shall be deemed to be representations and
warranties by the Company hereunder solely as of the date of such certificate or
instrument.
3.3 SUCCESSORS AND ASSIGNS. Except as otherwise expressly provided
herein, the provisions hereof shall inure to the benefit of, and be binding
upon, the successors, assigns, heirs, executors, and administrators of the
parties hereto and shall inure to the benefit of and be enforceable by each
person who shall be a holder of Registrable Securities from time to time;
PROVIDED, HOWEVER, that prior to the receipt by the Company of adequate written
notice of the transfer of any Registrable Securities specifying the full name
and address of the transferee, the Company may deem and treat the person listed
as the holder of such shares in its records as the absolute owner and holder of
such shares for all purposes, including the payment of dividends or any
redemption price.
3.4 ENTIRE AGREEMENT. The Transaction Documents constitute the full and
entire understanding and agreement between the parties with regard to the
subject matter hereof.
3.5 SEVERABILITY. In case any provision of this Rights Agreement shall
be invalid, illegal, or unenforceable, the validity, legality, and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby.
3.6 AMENDMENT AND WAIVER. Except as specifically set forth below, any
provision of this Rights Agreement may be amended and the observance thereof may
be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and the
Purchaser.
3.7 DELAYS OR OMISSIONS. It is agreed that no delay or omission to
exercise any right, power, or remedy accruing to the Purchaser, upon any breach,
default or noncompliance of the Company under this Rights Agreement shall impair
any such right, power, or remedy, nor shall it be construed to be a waiver of
any such breach, default or noncompliance, or any acquiescence therein, or of
any similar breach, default or noncompliance thereafter occurring. It is further
agreed that any waiver, permit, consent, or approval of any kind or character on
the Purchaser's part of any breach, default or noncompliance under this Rights
Agreement or any waiver on Purchaser's part of any provisions or conditions of
this Rights Agreement must be in writing and shall be effective only to the
extent specifically set forth in such writing. All remedies, either under this
Rights Agreement, by law, or otherwise afforded to the Purchaser, shall be
cumulative and not alternative.
3.8 NOTICES. All notices required or permitted hereunder shall be in
writing and shall be deemed effectively given: (i) upon personal delivery to the
party to be notified, (ii) when sent by confirmed telex or facsimile if sent
during normal business hours of the recipient; if not, then on the next business
day, (iii) five (5) days after having been sent by registered or certified mail,
return receipt requested, postage prepaid, (iv) one (1) day after deposit with a
nationally recognized overnight courier, specifying next day delivery, with
written verification of receipt, or (v) if earlier, upon receipt. All
communications shall be sent to the party to be notified at the address as set
forth on the signature page hereto or at such other address as such party may
designate by ten (10) days advance written notice to the other parties hereto.
11
3.9 ATTORNEYS' FEES. In the event that any dispute among the parties to
this Rights Agreement should result in litigation, the prevailing party in such
dispute shall be entitled to recover from the losing party all fees, costs and
expenses of enforcing any right of such prevailing party under or with respect
to this Rights Agreement, including without limitation, such reasonable fees and
expenses of attorneys and accountants, which shall include, without limitation,
all fees, costs and expenses of appeals.
3.10 TITLES AND SUBTITLES. The titles of the sections and subsections
of this Rights Agreement are for convenience of reference only and are not to be
considered in construing this Rights Agreement.
3.11 COUNTERPARTS. This Rights Agreement may be executed in any number
of counterparts, each of which shall be an original, but all of which together
shall constitute one instrument.
12
IN WITNESS WHEREOF, the parties hereto have executed this INVESTOR
RIGHTS AGREEMENT as of the date set forth in the first paragraph hereof.
COMPANY: PURCHASER:
TRIANGLE PHARMACEUTICALS, INC. GILEAD SCIENCES, INC.
By: /s/ XXXXXX X. XXXXX By: /s/ XXXX X. XXXXXX
----------------------------------- -----------------------------------
Name: Xxxxxx X. Xxxxx Name: Xxxx X. Xxxxxx
Title: Chairman and CEO Title: Chief Executive Officer
Address/Telephone/Facsimile: Address/Telephone/Facsimile:
0 Xxxxxxxxxx Xxxxx 000 Xxxxxxxx Xxxxx
0000 Xxxxxxxxxx Xxxxx Xxxxxx Xxxx, XX 00000
Xxxxxx, XX 00000 Tel: (000) 000-0000 Fax: (000) 000-0000
Tel: (000) 000-0000 Fax: (000) 000-0000
SIGNATURE PAGE FOR
INVESTOR RIGHTS AGREEMENT
